Grifols (GIFLF) Total Debt Growth (3y) (2012 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Total Debt Growth (3y) (2012 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -0.51% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -0.71% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 0.08% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 8.78% |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -1.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.55% |
| Dec 31, 2024 | -2.37% |
| Dec 31, 2023 | 12.40% |
| Dec 31, 2022 | 11.60% |
| Dec 31, 2021 | 17.06% |
| Dec 31, 2020 | 5.52% |
| Dec 31, 2019 | 14.35% |
| Sep 30, 2019 | 15.71% |
| Dec 31, 2018 | 10.96% |
| Sep 30, 2018 | 12.74% |
| Jun 30, 2018 | 3,124.89% |
| Mar 31, 2018 | 17.58% |
| Dec 31, 2017 | 9.47% |
| Jun 30, 2017 | 7.99% |
| Dec 31, 2016 | 11.72% |
| Sep 30, 2016 | 14.62% |
| Jun 30, 2016 | 14.78% |
| Mar 31, 2016 | 10.42% |
| Dec 31, 2015 | 12.48% |
| Sep 30, 2015 | 14.42% |